ONCOLINES B.V.

oncolines-bv-logo

Oncolines B.V. is a precision medicine services company in oncology and cancer immunotherapy.

#People #Website #More

ONCOLINES B.V.

Industry:
Health Care

Website Url:
http://www.oncolines.com

Status:
Active


Current Employees Featured

guido-zaman_image

Guido Zaman
Guido Zaman Managing Director and Founder @ Oncolines B.V.
Managing Director and Founder
2021-09-01

Official Site Inspections

http://www.oncolines.com

  • Host name: oncolines2.vps.warmstal.net
  • IP address: 136.144.244.187
  • Location: Eindhoven Netherlands
  • Latitude: 51.4513
  • Longitude: 5.4009
  • Timezone: Europe/Amsterdam
  • Postal: 5657

Loading ...

More informations about "Oncolines B.V."

Oncolines B.V.

Helping to bring Improved and Novel Therapies to the Right Patient Population Faster. Oncolines offers precision oncology services such as cancer cell lines, proliferation assays, drug โ€ฆSee details»

Symeres acquires Oncolines, further strengthening its drug โ€ฆ

Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities Nijmegen, the Netherlands: Symeres, a leading global drug discovery Contract Research โ€ฆSee details»

Symeres acquires Oncolines, further strengthening its โ€ฆ

Jan 10, 2023 Dr. Guido Zaman, Managing Director of Oncolines, stated: โ€œ We are excited to be joining Symeres, a leading transatlantic drug discovery contract research, development and manufacturing organization with over 30 years of โ€ฆSee details»

Oncolines - Crunchbase Company Profile & Funding

Oncolines is a precision medicine services company specializing in oncology and cancer immunotherapy. Oncolines clients are clinical and preclinical โ€ฆSee details»

Oncolines B.V. | LinkedIn

Oncolines B.V. (Oss, The Netherlands) is a precision medicine services company in oncology and cancer immunotherapy, part of Symeres B.V. (Nijmegen, The Netherlands). We help to bring โ€ฆSee details»

Oncolines B.V. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Oncolines B.V. of Oss, Noord-Brabant. Get the latest business insights from Dun & Bradstreet.See details»

Oncolines B.V. | About Oncolines

About Symeres Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug discovery and development challenges. With over 600 highly educated scientists โ€ฆSee details»

Oncolines - VentureRadar

Oncolines is a precision medicine services company in oncology and cancer immunotherapy. Our Clients are clinical and preclinical biopharma companies and academic institutions that seek โ€ฆSee details»

Oncolines Team Joins Symeres - Oncolines B.V.

Jan 10, 2023 Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities Nijmegen, the Netherlands: Symeres, a leading global drug discovery Contract โ€ฆSee details»

Oncolines 2025 Company Profile: Valuation, Investors ... - PitchBook

Information on acquisition, funding, investors, and executives for Oncolines. Use the PitchBook Platform to explore the full profile.See details»

Oncolines Company Profile - Office Locations, Competitors ... - Craft

See insights on Oncolines including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Oncolines B.V. - The Org

Oncolines B.V. (Oss, The Netherlands) is a precision medicine services company in oncology and cancer immunotherapy, part of Symeres B.V. (Nijmegen, The Netherlands). We help to bring โ€ฆSee details»

Oncolines - Contacts, Employees, Board Members, Advisors

Oncolines is a precision medicine services company specialising in oncology and cancer immunotherapy.See details»

10 years Pivot Park: Oncolines

โ€œOncolines is a subsidiary of the Netherlands Translational Research Center (NTRC), the company I started in 2012 with my MSD/Organon colleague Rogier Buijsman,โ€ says Zaman. โ€ฆSee details»

Symeres acquires Oncolines, further strengthening its drug โ€ฆ

Jan 10, 2023 Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), today announces the โ€ฆSee details»

Symeres acquires Oncolines, further strengthening its drug โ€ฆ

Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), announces the acquisition of โ€ฆSee details»

Oncolines® - Oncolines B.V.

Oncolines® Proliferation Assays and Biomarker Discovery. Helping you to find a mechanistic hypothesis for entering the clinic.See details»

Community and Advocacy Groups | Oncology Nursing Society

Mar 20, 2025 Cancer Active, Inc., is a nonprofit organization committed to improving the lives of individuals affected by cancer by focusing on wellness, education, and advocacy. Its mission is โ€ฆSee details»

Oncolines B.V. | Technology Platforms

Oncolines uses specialized technology platforms to aid in precision oncology tasks, such as patient stratification biomarker and combination therapy discovery.See details»

Oncolines B.V. | Oncolines Bioinformatics Gene Mutation Analysis

The mechanism of action of your compound can be investigated with response parameters of cancer cell line profiling without the need for additional experiments. For instance, we perform โ€ฆSee details»